A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

NCT00545233 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: peginterferon alfa-2a [Pegasys]
DRUG: ribavirin [Copegus]
DRUG: Pioglitazone

Sponsor

Hoffmann-La Roche